BioReg vs Curatron: Specification Comparison

Oscillating or impulse: what Curatron publishes about the split

Curatron is the only manufacturer in this comparison set that sells both approaches, which makes their written position on the difference worth reading directly. On the impulse side they state that “each individual high intensity impulse will go fully through the body,” that the pulses are “shorter in duration” than oscillating output, and that “the quantity of energy transferred by each pulse into the body is different from oscillating technology.”

On the oscillating side they state that “if looking exclusively for energy medicine like energizing the body, one might tend to opt for oscillating technology,” while noting that “full body penetration is less than with Flash technology.” They also disclose a side effect of the impulse line: “muscle contractions might occur in high settings.”

Two manufacturer positions on how to measure output sit side by side in this category. Pulse PEMF publishes no gauss figure and argues that gauss is not the meaningful number, pointing instead to how fast the field changes. Curatron publishes both gauss maxima and a pulse rise time of 140 micro seconds, and argues from the quantity of energy transferred per pulse. Both are manufacturers describing their own design philosophy. This page does not adjudicate between them.

The background on those two approaches, including what published research does and does not establish about intensity, is set out in high-intensity vs low-intensity PEMF. BioReg systems are low-intensity.

Where Curatron publishes more than BioReg

On disclosure, Curatron is ahead of us, and we would rather say so than leave a buyer to discover it. Curatron publishes per-model specification blocks covering intensity, waveform, pulse rate, program count and duration, dimensions, weight, input voltage and warranty. They publish a pulse rise time of 140 micro seconds. They publish the full selectable parameter set a user can build a protocol from, and offer the complete protocol list as a download. They publish open list pricing with checkout on every clinical model, accessories included. They disclose a side effect of their impulse line in their own material.

BioReg publishes a single intensity figure across the line, no rise time, program counts without the underlying selectable parameters, and quotes financing by inquiry above $5,000. That is less published detail than Curatron provides, and closing that gap is our work, not a point against them.

What does the published evidence say?

The BioReg research library holds 50 peer-reviewed studies, each graded on an A through F scale for design and sample quality, organized by condition with citations. Browse the research library or read how studies are graded. This page does not characterize Curatron’s evidence base; their own site describes their research position.